Target intelligence / Profile preview

Interferon regulatory factor 3 (IRF3)

Target
IRF3
Molecular classification
Transcription factor, DNA-binding protein, Member of the interferon regulatory factor (IRF) family
01

Overview

Interferon regulatory factor 3 (IRF3) is a constitutively expressed transcription factor in the cytoplasm, activated by viral infection or other innate immune stimuli[1][9]. It undergoes phosphorylation at multiple serine/threonine residues by kinases such as TBK1 and IKKε, leading to dimerization and translocation into the nucleus, where it binds DNA at interferon-stimulated response elements (ISREs) to induce type I interferon and ISG transcription[1][4][6][9]. IRF3 is essential in mounting antiviral defenses and fine-tuning inflammatory responses, and aberrations in its activity are linked to pathologies including viral susceptibility, chronic inflammation, and certain cardiovascular injuries[4][6][9].

Other names
IRF3Interferon-regulatory factor 3ISRE-binding protein
02

Mechanism of action

Inhibition of phosphorylation (preventing IRF3 activation and nuclear translocation); Blockade of dimerization (preventing transcriptional activity); Modulation of upstream kinases (TBK1, IKKε) or signaling adaptors (STING, MAVS, TRIF)

03

Biological functions

Regulation of interferon (IFN) expression (especially IFN-alpha and IFN-beta)Initiation of antiviral responseActivation of interferon-stimulated genes (ISGs)Signal transduction (in response to viral pattern recognition)Immune responseProtein phosphorylation and dimerization (key activation step)Cell death/apoptosis (in certain contexts)Transcriptional regulation
04

Disease associations

Infection (especially viral infection)Inflammation (innate immune signaling)Cancer (as part of immune surveillance, some oncogenic contexts)Cardiovascular disease (evidence for post-myocardial infarction involvement)Other (potential involvement in autoimmune and neurodegenerative diseases, but primary literature is focused on viral and inflammatory diseases)
05

Safety considerations

Modulation of IRF3 could impair host antiviral defense, increasing infection risk.Overactivation may drive excessive inflammation and/or autoimmunity.Targeting upstream kinases or adaptors that activate IRF3 (e.g., TBK1, STING) may affect other pathways, causing off-target effects
06

Biomarkers

Phosphorylated IRF3 (p-IRF3; marker of IRF3 activation)Type I interferon levels (as downstream readout)ISG expression panel (monitoring pathway activity)

Beyond the preview

Go deeper on Interferon regulatory factor 3 (IRF3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon regulatory factor 3 (IRF3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call